International AIDS Society announces Dr Annette Sohn as new JIAS Editor-in-Chief

The International AIDS Society (IAS) announced today that Dr Annette Sohn is a new Editor-in-Chief of the Journal of the International AIDS Society (JIAS).

Dr Sohn is a Vice President of amfAR, the Foundation for AIDS Research and the Director of amfAR’s TREAT (Therapeutics Research, Education and AIDS Training) Asia programme in Bangkok, Thailand.

TREAT Asia is a collaborative network of clinics, hospitals and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific region through research, education, community advocacy and policy.

Dr Sohn’s own research focuses on long-term treatment outcomes of children and adolescents living with HIV.

“Dr Sohn is a highly esteemed clinician and researcher whose work in paediatric HIV is incredibly vital to the field,” IAS President Linda-Gail Bekker said. “She also brings expertise in bridging research, with clinical training, community outreach and advocacy that will no doubt reflect upon and strengthen future JIAS scholarship. This is a greatly welcomed addition to the team.”

Since its establishment in 2001, TREAT Asia has served as a distinctive model for regional collaboration, bringing together researchers, clinicians, community advocates and policymakers to make the case for evidenced-based HIV responses in the Asia-Pacific region.

“I am honoured to be joining the editorial team at JIAS,” Dr Sohn said. “The field of HIV research is constantly expanding with innovative studies that bring us closer to ending the global epidemic. I look forward to helping expand a knowledge base that has the potential to benefit millions of lives worldwide.”

Dr Sohn is also currently a member of the World Health Organization’s Strategic and Technical Advisory Committee on HIV and Viral Hepatitis, the Global Validation Advisory Committee on Elimination of Mother-to-Child Transmission of HIV and Syphilis, and the Program Committee of the Conference on Retroviruses and Opportunistic Infections.

 

LEAVE A REPLY